Table 2 Clinical findings and treatment procedures
Feature | Number of Patients (n = 107) | %* |
|---|---|---|
Gender | Â | Â |
   Male | 83 | 78 |
   Female | 24 | 22 |
Age (years) | Â | Â |
   Median | 62.3 | |
   Range | 36 - 81 | |
Tumor Distance from Anal Verge (cm) | Â | Â |
   0-6 | 53 | 50 |
   >6-12 | 47 | 44 |
   >12-16 | 7 | 7 |
cT Stage | Â | Â |
   1 | 0 | 0 |
   2 | 1 | 1 |
   3 | 98 | 92 |
   4 | 8 | 7 |
cN Stage | Â | Â |
   Positive | 82 | 77 |
   Negative | 25 | 23 |
cUICC Stage | Â | Â |
   I | 0 | 0 |
   II | 25 | 23 |
   III | 82 | 77 |
   IV | 0 | 0 |
Neoadjuvant Treatment | Â | Â |
   50.4 Gy + standard 5-FU | 84 | 79 |
   50.4 Gy + intensified 5-FU/Oxaliplatin | 23 | 21 |
Surgical Procedure (including TME) | Â | Â |
   Low Anterior Resection (incl. laparoscopic) | 63 (2) | 59 (2) |
   Abdominoperineal Resection (incl. laparoscopic) | 43 (1) | 40 (1) |
   Hartmann's Procedure | 1 | 1 |